Form D · Biotechnology
Sanuthera, Inc.
Athens, OH · CIK 0001621997
Offering snapshot reported Oct 15, 2014 · SEC filing
- Reported sold
- $101K Offering amount: $1.2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Oct 1, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2014 | Initial | $100,697 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-226512
Source: Form D, filed Oct 15, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Dickey | Director |
| Jeffrey Di Giovanni | Director, Executive |
| Rick Giancola | Director |
| Mark Hendrickson | Director |
| Jane New | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
340 West State Street, Unit 45
Athens, OH, 45701
Athens, OH, 45701